cgp 52411 has been researched along with Carcinoma, Epidermoid in 4 studies
4,5-dianilinophthalimide: structure given in first source
4,5-dianilinophthalimide : Phthalimide substituted at the 4- and 5-positions by anilino groups.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hagmann, W | 2 |
Borgers, S | 2 |
Buchdunger, E | 1 |
Mett, H | 1 |
Trinks, U | 1 |
Regenass, U | 1 |
Müller, M | 1 |
Meyer, T | 1 |
Beilstein, P | 1 |
Wirz, B | 1 |
Schneider, P | 1 |
Traxler, P | 1 |
Lichtner, RB | 1 |
Menrad, A | 1 |
Sommer, A | 1 |
Klar, U | 1 |
Schneider, MR | 1 |
4 other studies available for cgp 52411 and Carcinoma, Epidermoid
Article | Year |
---|---|
Requirement for epidermal growth factor receptor tyrosine kinase and for 12-lipoxygenase activity in the expression of 12-lipoxygenase in human epidermoid carcinoma cells.
Topics: Arachidonate 12-Lipoxygenase; Biotin; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Do | 1997 |
EGF-receptor tyrosine kinase and 12-lipoxygenase activity regulate expression of 12-lipoxygenase in human tumor cells.
Topics: Arachidonate 12-Lipoxygenase; Biotin; Carcinoma, Squamous Cell; Enzyme Induction; Enzyme Inhibitors; | 1997 |
4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Biotransformation; Carcinoma, Squamous Cell; Cell Line, T | 1995 |
Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Division; Enzyme In | 2001 |